| Product Code: ETC9493714 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sudan Lung Cancer Therapeutics Market Overview |
3.1 Sudan Country Macro Economic Indicators |
3.2 Sudan Lung Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Sudan Lung Cancer Therapeutics Market - Industry Life Cycle |
3.4 Sudan Lung Cancer Therapeutics Market - Porter's Five Forces |
3.5 Sudan Lung Cancer Therapeutics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Sudan Lung Cancer Therapeutics Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.7 Sudan Lung Cancer Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 Sudan Lung Cancer Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
4 Sudan Lung Cancer Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Sudan |
4.2.2 Growing awareness about the importance of early detection and treatment |
4.2.3 Advancements in lung cancer therapeutics and technologies |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Sudan |
4.3.2 High cost of lung cancer treatments |
4.3.3 Lack of skilled healthcare professionals specializing in lung cancer care in Sudan |
5 Sudan Lung Cancer Therapeutics Market Trends |
6 Sudan Lung Cancer Therapeutics Market, By Types |
6.1 Sudan Lung Cancer Therapeutics Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021- 2031F |
6.1.4 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Metastatic Lung Cancer, 2021- 2031F |
6.1.5 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Pulmonary Neuroendocrine Tumors, 2021- 2031F |
6.1.6 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Mediastinal Tumors, 2021- 2031F |
6.1.7 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Mesothelioma, 2021- 2031F |
6.1.8 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Chest Wall Tumors, 2021- 2031F |
6.2 Sudan Lung Cancer Therapeutics Market, By Molecule Type |
6.2.1 Overview and Analysis |
6.2.2 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.2.3 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Biologics, 2021- 2031F |
6.3 Sudan Lung Cancer Therapeutics Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Alkylating Agents, 2021- 2031F |
6.3.3 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.3.4 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By EGFR Inhibitors, 2021- 2031F |
6.3.5 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Mitotic Inhibitors, 2021- 2031F |
6.3.6 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Multikinase Inhibitors, 2021- 2031F |
6.4 Sudan Lung Cancer Therapeutics Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.3 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.4.4 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.4.5 Sudan Lung Cancer Therapeutics Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
7 Sudan Lung Cancer Therapeutics Market Import-Export Trade Statistics |
7.1 Sudan Lung Cancer Therapeutics Market Export to Major Countries |
7.2 Sudan Lung Cancer Therapeutics Market Imports from Major Countries |
8 Sudan Lung Cancer Therapeutics Market Key Performance Indicators |
8.1 Number of lung cancer screenings conducted annually |
8.2 Percentage of lung cancer patients receiving timely and appropriate treatment |
8.3 Rate of adoption of advanced lung cancer therapeutics in Sudan |
9 Sudan Lung Cancer Therapeutics Market - Opportunity Assessment |
9.1 Sudan Lung Cancer Therapeutics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Sudan Lung Cancer Therapeutics Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.3 Sudan Lung Cancer Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 Sudan Lung Cancer Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10 Sudan Lung Cancer Therapeutics Market - Competitive Landscape |
10.1 Sudan Lung Cancer Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Sudan Lung Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here